ASCOT is a clinical trial that will generate clinical evidence about treatment for COVID-19 that can be applied during the pandemic to reduce mortality or the need for mechanical ventilation in hospitalised but not yet critically ill patients with COVID-19.
Following an observational study published in The Lancet on Friday, 22 May, the AustralaSian COVID-19 Trial (ASCOT) has paused patient recruitment pending deliberations by the governance and ethics committees overseeing the trial.
Nearly every aspect of our daily lives has been changed in some way by the COVID-19 pandemic. One area which has been highly affected, but which many people don’t consciously notice, is our use of language.
As part of the ASCOT trial, we are establishing a collection of blood and other samples that are donated by people enrolled in the study, which will be used for research, immediately and into the future.
